CSU’s BioMARC awarded $4.6M contract to develop new encephalitis vaccines

CSU’s BioMARC awarded $4.6M contract to develop new encephalitis vaccines

FORT COLLINS -- Colorado State University today announced its Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) has been awarded a 10-month, $4.6 million contract from the... Read More

Wednesday January 13, 2016 0 comments Tags: Fort Collins, CSU BioMARC, Dennis Pierro, DOD, Ebola virus, Marburg virus, encephalitis

Lancet: Corgenix’s Ebola rapid diagnostic test proven effective in west Africa outbreak

Lancet: Corgenix’s Ebola rapid diagnostic test proven effective in west Africa outbreak

DENVER -- Corgenix Medical Corporation s Ebola rapid diagnostic test (RDT) has been proven to be highly accurate in an independent study published by the British medical journal Lancet . The... Read More

By: InnovatioNews Wednesday July 1, 2015 0 comments Tags: Denver, Corgenix, Ebola virus, ReEBOV Antigen Rapid, James Widergren

CSU's BioMARC awarded $2M to help develop Ebola, filovirus vaccine

CSU's BioMARC awarded $2M to help develop Ebola, filovirus vaccine

FORT COLLINS - Colorado State University's Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) has been awarded $2 million by the U.S. Department of Defense to aid in the... Read More

By: InnovatioNews Monday October 27, 2014 0 comments Tags: CSU BioMARC, Dennis Pierro, Ebola virus, Fort Collins

Corgenix working on Ebola test kit but likely won't be ready for current outbreak

Corgenix working on Ebola test kit but likely won't be ready for current outbreak

BROOMFIELD - Corgenix Medical Corp. (OTCBB: CONX) announced it is working to develop a diagnostic test kit for the Ebola virus but won't likely be able to provide the kit for the current... Read More

By: InnovatioNews Tuesday August 12, 2014 0 comments Tags: Broomfield, Corgenix, Douglass Simpson, Ebola virus, NIH

Corgenix research group announces NIH grant to advance Ebola rapid diagnostic test kit

Corgenix research group announces NIH grant to advance Ebola rapid diagnostic test kit

  DENVER -- Corgenix Medical Corporation (OTC BB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, has been awarded a three-year, $2.9 million National Institutes of... Read More

By: InnovatioNews Friday June 27, 2014 0 comments Tags: Corgenix, Denver, Douglass Simpson, Ebola virus, NIH

Corgenix extending viral hemorrhagic fever rapid test to include Ebola to address African outbreak

Corgenix extending viral hemorrhagic fever rapid test to include Ebola to address African outbreak

DENVER - An outbreak of deadly Ebola virus in West Africa has prompted Denver-based Corgenix Medical Corp. (OTCBB: CONX) to extend its existing viral hemorrhagic fever (VHF) rapid test... Read More

By: InnovatioNews Tuesday April 1, 2014 0 comments Tags: Corgenix, Denver, Douglass Simpson, Ebola virus, Lassa virus, Robert Garry